The United States has a troubling history of black bodies being used as experimental subjects for new drugs or medical treatments. Though the NIH Revitalization Act of 1993 was created to require the inclusion of women and minorities in clinical trials funded by the NIH, Black participation in clinical trials still trails far below the overall demographic makeup of the US. While mistrust of medical research and clinical trials among many black people still exists, exacerbated by medical racism, which affects the extent to which black patients are exposed to and able to access clinical trials. 

In this episode of the Health EquiTEA Podcast, Dr. Jallicia Jolly and Dr. Ijeoma Kola highlight the overlap between Black underrepresentation in clinical trials and the disproportionate impact of Breast cancer in Black women. Breast cancer survivors Ricki Fairley and Valarie Worthy, the co-founders of Touch, the Black Breast Cancer Alliance, join the Health EquiTEA podcast to discuss their mission to increase Black women's participation in breast cancer clinical trials. Through their organization, Ricki and Valarie are working to reduce racial inequities in breast cancer outcomes by increasing access to advanced treatment and life-saving quality care for Black women, while also promoting Black breast health awareness in younger generations.

For detailed show notes, visit healthequitea.com/episodes/narrowing-the-gap-in-black-breast-health

Stay Connected

• Tweet us at @Health_EquiTEA, @Jallicia, and @IjeomaKola
• Visit our website healthequitea.com
• Email us at healthequiteapodcast@gmail.com

If you liked this episode, please leave us a review!